Tarsier Pharma
TARXBiotech & Healthcare · NASDAQ · IPO April 21, 2026
01
Company Overview
Tarsier Pharma is filing to list on an exchange. Public information at this stage is limited to the IPO calendar entry; deeper detail typically becomes available closer to pricing via the company's S-1 / prospectus.
Tarsier Pharma is going public on an exchange on 2026-04-21.
Recent headlines
- Tarsier Pharma, Ophthalmic Biopharmaceutical Developer ...firstwordpharma.com
Tarsier Pharma, an Israel-based ophthalmic biopharmaceutical company, has filed for an IPO on the NYSE under the ticker "TARX," seeking funds to
- TARX | Tarsier Pharma - Pre-IPOmarketwatch.com
Tarsier Pharma ; At a Glance. Company. Tarsier Pharma ; Filing Information. File Date. 4/21/2026 ; Financial Information. Ltm Date. N/A.
- Tarsier Pharma files for proposed NYSE IPOinvesting.com
Tarsier Pharma has on Tuesday filed for a proposed NYSE IPO. The company describes itself as: "We are a late clinical stage biopharmaceutical ...
- Israel-based Phase 3 ocular diseases biotech Tarsier Pharma ...renaissancecapital.com
The Zichron Yaacov, Israel-based company was founded in 2016 and plans to list on the NYSE American under the symbol TARX. Tarsier Pharma filed ...
- Tarsier Pharma Files for Initial Offering on NYSEmoomoo.com
The company aims to trade on the New York Stock Exchange under the ticker TARX, it said in a Securities and Exchange Commission filing Tuesday.
02
AI Analysis
Possible growth narrative
Sits adjacent to Biotech & Healthcare — themes that are currently drawing meaningful capital and attention.
Risks
Newly public companies typically face limited operating history disclosure, lock-up expirations, and broader market sentiment swings around IPOs.
Volatility
Expect elevated price volatility in the first weeks of trading as supply and demand find balance.
Market attention
Recently listed — monitoring early trading activity and analyst initiations.
Educational summary only. Not investment advice.
03
Related Themes
04
IPO Information
- IPO date
- April 21, 2026
- Exchange
- NASDAQ
- Status
- Recently Listed
- Industry
- Biotech & Healthcare
- Valuation
- $34.5M raise
- Headquarters
- —
- Attention score
- 46 / 100
- Ticker
- TARX